Antares Pharma Inc (NASDAQ:ATRS) announced 4Q2013 and FY2013 results before the market open on March 13, and investors weren’t impressed. The company reported 4Q2013 loss of $0.04 per share on revenue of $4.7m, which was pretty much in-line with my expectations, but the stock ended up closing down over 5.6% on twice the average daily volume. Antares Pharma Inc (NASDAQ:ATRS) shares after opening at $3.55 moved to $3.61 on last trade day and at the end of the day closed at $ 3.50. Company price to sales ratio in past twelve months was calculated as 22.07 and price to cash ratio as 7.21. Antares Pharma Inc (NASDAQ:ATRS) showed a negative weekly performance of -7.41%.
Neustar, Inc. (NYSE:NSR) a trusted, neutral provider of real-time information and analytics, announced PlatformOne, a single interface that integrates real-time customer and media insights with the tools to activate more tailored and personalized campaigns, both offline and online. PlatformOne streamlines a complex marketing. Neustar Inc (NYSE:NSR) shares fell -2.17% in last trading session and ended the day on $32.51. NSR return on equity ratio is recorded as 25.60% and its return on assets is 10.60%. Neustar Inc (NYSE:NSR) yearly performance is -27.80%.
Varonis Systems Inc (NASDAQ:VRNS) is now covered by analysts at Barclays. They set an “equal weight” rating and a $42.00 price target on the stock. They noted that the move was a valuation call. They noted that the move was a valuation call. Varonis Systems Inc (NASDAQ:VRNS) shares moved up 1.94% in last trading session and was closed at $35.76 while trading in range of $33.61 – $36.71 – Varonis Systems Inc (NASDAQ:VRNS) year to date (YTD) performance is -19.75%.
The Medicines Company (NASDAQ:MDCO) was downgraded by equities research analysts at TheStreet from a “buy” rating to a “hold” rating in a research note issued to investors on Monday, StockRatingsNetwork reports. The Medicines Company (NASDAQ:MDCO) weekly performance is -2.74%. On last trading day company shares ended up $28.42. The Medicines Company (NASDAQ:MDCO) distance from 50-day simple moving average (SMA50) is -11.30%. Analysts mean target price for the company is $37.82.